CENTENIAL SURGICAL SUTURE LTD.

Centenial Surgical Suture Ltd. has submitted its 31st Annual Report for the financial year 2025-2026 to the BSE, in compliance with Regulation 34 of SEBI (LODR) Regulations, 2015. The report includes the notice for the 31st Annual General Meeting (AGM), scheduled for September 28, 2026, to be held via Video Conferencing/Other Audio-Visual Means. The company has also made the Annual Report available on its website. The filing details the company's registered office, manufacturing facilities, and corporate information, including the Board of Directors as of August 14, 2026, CFO, COO, and Company Secretary. It also lists the company's bankers, auditors, and registrars. The report contains forward-looking statements regarding the company's prospects, subject to risks and uncertainties.

Centenial Surgical Suture Ltd has announced its 31st Annual General Meeting (AGM) will be held on September 28, 2026, at 2:00 PM IST via Video Conferencing. The company is providing access to the Notice of the AGM and the Annual Report for FY 2025-2026 through a web-link for shareholders who have not registered their email addresses. This communication also serves as a reminder for shareholders holding physical securities to update their KYC details as per SEBI's latest circular, including PAN, address, bank details, and nomination, to ensure continued eligibility for payments like dividends.

Centenial Surgical Suture Ltd has announced its 31st Annual General Meeting (e-AGM) to be held on September 28, 2026, via Video Conference. The meeting will discuss the adoption of audited accounts for FY 2025-2026 and the re-appointment of Anuradha Kashikar as Executive Director for three years. The company is submitting its Annual Report and e-AGM Notice as per SEBI regulations. Shareholders can access these documents online.

Centennial Surgical Suture Ltd. has alerted the stock exchanges to suspicious and potentially manipulative trading in its scrip. The company notes frequent instances where only a single equity share has been traded, leading to significant price increases, such as a 4.64% rise on a single share trade on January 26, 2026, and a 4.99% rise on January 21, 2026. These patterns, occurring with minimal volume, are not supported by any corporate announcements or material business changes. The company suspects price rigging and coordinated trading within a syndicate to artificially inflate the share price, requesting an urgent investigation by SEBI and BSE.

Centenial Surgical Suture Ltd has announced that its 31st Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 02:00 p.m. The meeting will be conducted through Video Conferencing/Other Audio-Visual Means, adhering to MCA and SEBI circulars. The cut-off date for determining voting eligibility for remote e-voting and e-voting during the AGM is Monday, September 21, 2026. The e-voting period will commence on Thursday, September 24, 2026, at 9:00 a.m. (IST) and conclude on Sunday, September 27, 2026, at 5:00 p.m. (IST), providing members with electronic voting facilities on all resolutions.

Centenial Surgical Suture Ltd has announced that its Board of Directors, in a meeting held on August 14, 2026, approved the dates for the closure of its Share Transfer Books and Register of Members. The closure will be effective from Tuesday, September 22, 2026, to Monday, September 28, 2026, inclusive. This period is designated for the company's 31st Annual General Meeting (AGM), which is scheduled to be held on Monday, September 28, 2026. The company has informed the relevant depositories and registrars about this decision.

Centenial Surgical Suture Ltd announced a change in its Chief Financial Officer (CFO) and Key Managerial Personnel. Ms. Sapna Mahtre has been appointed as the new CFO, effective August 14, 2026. Concurrently, Ms. Anuradha Kashikar has resigned from the position of CFO and Key Managerial Personnel, also effective August 14, 2026. Ms. Mahtre, who has been with the company since September 2001 as Chief Administrative Officer, will now oversee the company's finance and accounts functions. The board meeting where these decisions were made commenced at 5:00 p.m. and concluded at 5:30 p.m. on August 14, 2026. The company has also stated that this information will be available on its website.

Centenial Surgical Suture Ltd announced the re-appointment of Ms. Anuradha Kashikar as an Executive Director for a term of three years, effective April 1, 2027, to March 31, 2030. This decision was approved by the Board of Directors following a recommendation from the Nomination and Remuneration Committee. The re-appointment is subject to shareholder approval at the upcoming 31st Annual General Meeting. Ms. Kashikar has been an Executive Director since March 27, 2015, and her current term expires on March 31, 2027. The company highlighted her extensive experience and knowledge as beneficial to the organization. Remuneration for Ms. Kashikar is reported as Nil and will be detailed in the Corporate Governance Report.

Centenial Surgical Suture Ltd has announced the appointment of M/s. Utsav Shah & Associates, Chartered Accountants, as its Internal Auditors for the Financial Year 2026-2027. The decision was made by the Audit Committee and the Board of Directors during their meeting held on August 14, 2026. This appointment is in compliance with the Companies Act, 2013, and SEBI (LODR) Regulations, 2015. The firm, with FRN 140896W, brings approximately a decade of experience in auditing and assurance. The information is disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015, and will be available on the company's website.

Centenial Surgical Suture Ltd. has announced its standalone un-audited financial results for the quarter ended June 30, 2026. The company submitted the financial results along with the Limited Review Report as per SEBI regulations. The board meeting to approve these results commenced at 5:00 p.m. and concluded at 5:30 p.m. on August 14, 2026. The results are available on the BSE website and the company's website.